🇺🇸 FDA

Intelligence · Clinical Pipeline

Takeda Pipeline

All ClinicalTrials.gov programs at Takeda — phase, modality, and trial IDs.

Programs
1,179

Quick answer

Takeda has 1,179 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Vedolizumab IV

    Takeda

    Crohn's Disease

    phase 3 small molecule active

    2 trials

  2. Vedolizumab IV

    Takeda

    Crohn's Disease (CD)

    phase 3 small molecule active

    1 trial

  3. Vedolizumab IV

    Takeda

    Moderately to Severely Active Ulcerative Colitis

    phase 3 small molecule active

    1 trial

  4. Vedolizumab Placebo

    Takeda

    Hematopoietic Stem Cells

    phase 3 small molecule completed

    1 trial

  5. Vedolizumab SC

    Takeda

    Ulcerative Colitis

    phase 3 small molecule active

    1 trial

  6. Vedolizumab SC

    Takeda

    Colitis, Ulcerative

    phase 3 small molecule completed

    1 trial

  7. Vedolizumab SC 108 mg

    Takeda

    Crohn's Disease

    phase 3 small molecule completed

    1 trial

  8. Venticute

    Takeda

    Pneumonia

    phase 3 small molecule completed

    1 trial

  9. Vonicog Alfa

    Takeda

    Von Willebrand Disease (VWD)

    phase 3 mab active

    1 trial

  10. Vonicog alfa

    Takeda

    Von Willebrand Disease

    phase 3 mab completed

    1 trial

  11. Vonoprazan

    Takeda

    Helicobacter Pylori

    phase 3 small molecule completed

    1 trial

  12. Vonoprazan

    Takeda

    Healthy Volunteers

    phase 3 small molecule completed

    1 trial

  13. Vortioxetine

    Takeda

    TBI

    phase 3 small molecule terminated

    1 trial

  14. Vortioxetine

    Takeda

    Treatment Outcome

    phase 3 small molecule completed

    1 trial

  15. Vortioxetine

    Takeda

    Major Depressive Disorder

    phase 3 small molecule completed

    9 trials

  16. Vortioxetine

    Takeda

    Depressive Disorder, Major

    phase 3 small molecule completed

    5 trials

  17. Vortioxetine

    Takeda

    Generalized Anxiety Disorder

    phase 3 small molecule completed

    3 trials

  18. Vortioxetine 10 mg/day

    Takeda

    Depressive Disorder, Major

    phase 3 small molecule completed

    2 trials

  19. Vortioxetine tablets

    Takeda

    Major Depressive Disorder

    phase 3 small molecule active

    1 trial

  20. Vyvanse (lisdexamfetamine dimesylate)

    Takeda

    ADHD

    phase 3 small molecule completed

    1 trial

  21. YF-17D

    Takeda

    Dengue

    phase 3 mab completed

    1 trial

  22. ZASOCITINIB

    Takeda

    Moderate to Severe Plaque Psoriasis

    phase 3 small molecule active

    1 trial

  23. Zasocitinib

    Takeda

    Psoriatic Arthritis

    phase 3 small molecule active

    3 trials

  24. Zasocitinib

    Takeda

    Plaque Psoriasis

    phase 3 small molecule active

    2 trials

  25. agalsidase alfa

    Takeda

    Fabry Disease

    phase 3 mab completed

    3 trials

  26. alpha1-proteinase inhibitor

    Takeda

    Covid19

    phase 3 small molecule terminated

    1 trial

  27. brentuximab vedotin

    Takeda

    Hodgkin Lymphoma

    phase 3 small molecule completed

    3 trials

  28. brigatinib

    Takeda

    Non-Small Cell Lung Cancer

    phase 3 small molecule terminated

    2 trials

  29. candesartan

    Takeda

    Type 2 Diabetes

    phase 3 small molecule completed

    1 trial

  30. candesartan

    Takeda

    Type 1 Diabetes

    phase 3 small molecule completed

    1 trial

  31. candesartan cilexetil

    Takeda

    Type 1 Diabetes

    phase 3 small molecule completed

    1 trial

  32. ciclesonide

    Takeda

    Asthma

    phase 3 small molecule completed

    2 trials

  33. ciclesonide (XRP1526)

    Takeda

    Respiratory Tract Diseases

    phase 3 small molecule completed

    1 trial

  34. cyclosporine

    Takeda

    Leukemia

    phase 3 small molecule terminated

    1 trial

  35. ecallantide

    Takeda

    Hereditary Angioedema (HAE)

    phase 3 small molecule completed

    4 trials

  36. elritercept, Placebo to match ker-050 solution for injection

    Takeda

    myelodysplastic neoplasms/syndromes (MDS)

    phase 3 small molecule active

    1 trial

  37. extended-release guanfacine hydrochloride (SPD503)

    Takeda

    Attention-Deficit/Hyperactivity Disorder

    phase 3 small molecule completed

    1 trial

  38. hydrocortisone (modified release), oral tablet 20 and 5 mg

    Takeda

    Adrenal Insufficiency

    phase 3 small molecule completed

    1 trial

  39. icatibant

    Takeda

    Hereditary Angioedema (HAE)

    phase 3 small molecule completed

    2 trials

  40. idursulfase-IT

    Takeda

    Hunter Syndrome

    phase 3 mab active

    4 trials

  41. maribavir

    Takeda

    Cytomegalovirus Infections

    phase 3 small molecule completed

    2 trials

  42. maribavir, Maribavir, LIVTENCITY 200 mg film-coated tablets., Maribavir

    Takeda

    Cytomegalovirus (CMV) infection in children and adolescents who have received a hematopoietic stem cell transplant (HSCT) or a solid organ transplant (SOT)

    phase 3 small molecule active

    1 trial

  43. omega-3-acid ethyl esters 90 (TAK-085)

    Takeda

    Hypertriglyceridemia

    phase 3 small molecule completed

    2 trials

  44. oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab

    Takeda

    Colorectal Cancer

    phase 3 small molecule completed

    1 trial

  45. pantoprazole 20 mg (drug)

    Takeda

    Chronic Use of Acid Suppressive Medication

    phase 3 small molecule active

    1 trial

  46. peginesatide

    Takeda

    Chronic Renal Failure

    phase 3 small molecule completed

    4 trials

  47. pioglitazone

    Takeda

    Stroke

    phase 3 small molecule completed

    1 trial

  48. placebo

    Takeda

    Osteoporosis

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Takeda have?

1,179 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.